Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2024

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from______ to ______

A SPAC II ACQUISITION CORP.

(Exact Name of Registrant as Specified in Charter)

British Virgin Islands		001-41372		n/a
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

289 Beach Road

#03-01

Singapore 199552

(Address of Principal Executive Offices) (Zip Code)

(65) 6818 5796

(Registrant’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one Class A ordinary share, with no par value, one-half of one redeemable warrant and one right to receive one-tenth of one Class A ordinary share	ASCBU	The Nasdaq Global Market
Class A ordinary shares, no par value, included as part of the units	ASCB	The Nasdaq Global Market
Redeemable warrants, each whole warrant exercisable for one Class A ordinary share, included as part of the units	ASCBW	The Nasdaq Global Market
Rights, each Right to receive one-tenth (1/10) of one Class A ordinary share included as part of the units	ASCBR	The Nasdaq Global Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

As of May 9, 2024, 7,196,395 Class A Ordinary Shares and 100,000 Class B Ordinary Shares, were issued and outstanding.

TABLE OF CONTENTS

Part I - FINANCIAL INFORMATION		1

Item 1.	Unaudited Condensed Financial Statements	1

	Unaudited Condensed Balance Sheets as of March 31, 2024 and December 31, 2023	1

	Unaudited Condensed Statements of Income for the three months ended March 31, 2024 and 2023	2

	Unaudited Condensed Statements of Changes in Shareholders’ Deficit for the three months ended March 31, 2024 and 2023	3

	Unaudited Condensed Statements of Cash Flows for the three months ended March 31, 2024 and 2023	4

	Notes to Unaudited Condensed Financial Statements	5

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	16

Item 3.	Quantitative and Qualitative Disclosures about Market Risk	19

Item 4.	Controls and Procedures	20

Part II - OTHER INFORMATION		21

Item 1.	Legal Proceedings	21

Item 1A.	Risk Factors	21

Item 2.	Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities	21

Item 3.	Defaults Upon Senior Securities	21

Item 4.	Mine Safety Disclosures	21

Item 5.	Other Information	21

Item 6.	Exhibits	22

SIGNATURES		23

CAUTIONARY NOTE CONCERNING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are not historical facts, and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023 filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 29, 2024 and the Company’s final prospectus for its initial public offering filed with the SEC on May 3, 2022. The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

PART I - FINANCIAL INFORMATION

Item 1. Unaudited Condensed Financial Statements

A SPAC II ACQUISITION CORP.

CONDENSED BALANCE SHEETS

	March 31, 2024 (Unaudited)			December 31, 2023

Assets
Current assets:
Cash	$	252,438		$	442,147
Prepaid expenses		93,255			34,489
Total current assets		345,693			476,636

Investments held in Trust Account		22,181,297			21,895,685
Total Assets	$	22,526,990		$	22,372,321

Liabilities, Shares Subject to Redemption and Shareholders’ Deficit
Current liabilities:
Accounts payable and accrued expenses	$	169,678		$	157,354
Total current liabilities		169,678			157,354

Deferred underwriting fee payable		7,000,000			7,000,000
Total Liabilities		7,169,678			7,157,354

Commitments and Contingencies (Note 6)

Class A ordinary shares subject to possible redemption, no par value; 1,996,395 shares at redemption value of $11.111 and $10.968 per share as of March 31, 2024 and December 31, 2023, respectively		22,181,297			21,895,685

Shareholders’ Deficit
Preference shares, no par value; 1,000,000 shares authorized; none issued and outstanding		—			—
Class A ordinary shares, no par value; 500,000,000 shares authorized; 5,200,000 shares issued and outstanding (excluding 1,996,395 shares subject to possible redemption) as of March 31, 2024 and December 31, 2023		—			—

Class B ordinary shares, no par value; 50,000,000 shares authorized; 100,000 shares issued and outstanding as of March 31, 2024 and December 31, 2023		—			—
Additional paid-in capital		—			—
Accumulated deficit		(6,823,985	)		(6,680,718	)
Total Shareholders’ Deficit		(6,823,985	)		(6,680,718	)
Total Liabilities, Shares Subject to Redemption, and Shareholders’ Deficit	$	22,526,990		$	22,372,321

The accompanying notes are an integral part of these unaudited condensed financial statements.

A SPAC II ACQUISITION CORP.

UNAUDITED CONDENSED STATEMENTS OF INCOME

	For the Three Months Ended March 31,
	2024			2023

General and administrative expenses	$	148,651		$	197,239
Loss from operations		(148,651	)		(197,239	)
Other income:
Interest income		290,996			2,199,283
Income before income taxes		142,345			2,002,044
Income taxes provision		—			—
Net income	$	142,345		$	2,002,044

Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption		1,996,395			20,300,000
Basic and diluted net income per share, Class A ordinary shares subject to possible redemption	$	0.12		$	0.10
Basic and diluted weighted average shares outstanding, Class A and Class B ordinary shares not subject to redemption		5,300,000			5,000,000
Basic and diluted net loss per share, Class A and Class B ordinary shares not subject to redemption	$	(0.02	)	$	(0.01	)

The accompanying notes are an integral part of these unaudited condensed financial statements.

A SPAC II ACQUISITION CORP.

UNAUDITED CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS’ DEFICIT

For the Three Months Ended March 31, 2024

	Ordinary Shares								Additional					Total
	Class A				Class B				Paid-in		Accumulated			Shareholders’
	Shares		Amount		Shares		Amount		Capital		Deficit			Deficit
Balance –December 31, 2023		5,200,000	$	—		100,000	$	—	$	—	$	(6,680,718	)	$	(6,680,718	)

Accretion of Class A ordinary shares to redemption value		—		—		—		—		—		(285,612	)		(285,612	)
Net Income		—		—		—		—		—		142,345			142,345
Balance – March 31, 2024		5,200,000	$	—		100,000	$	—	$	—	$	(6,823,985	)	$	(6,823,985	)

For the Three Months Ended March 31, 2023

	Ordinary Shares								Additional					Total
	Class A				Class B				Paid-in		Accumulated			Shareholders’
	Shares		Amount		Shares		Amount		Capital		Deficit			Deficit
Balance –December 31, 2022		300,000	$	—		5,000,000	$	—	$	—	$	(5,873,067	)	$	(5,873,067	)

Accretion of Class A ordinary shares to redemption value		—		—		—		—		—		(2,189,543	)		(2,189,543	)
Net Income		—		—		—		—		—		2,002,044			2,002,044
Balance – March 31, 2023		300,000	$	—		5,000,000	$	—	$	—	$	(6,060,566	)	$	(6,060,566	)

The accompanying notes are an integral part of these unaudited condensed financial statements.

A SPAC II ACQUISITION CORP.

UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS

	For the Three Months Ended March 31, 2024			For the Three Months Ended March 31, 2023
Cash flows from operating activities:
Net income	$	142,345		$	2,002,044
Adjustments to reconcile net income to net cash used in operating activities:
Interest earned in trust account		(285,612	)		(2,189,543	)
Change in operating assets and liabilities:
Prepaid expenses and other assets		(58,766	)		11,333
Accounts payable and accrued expenses		12,324			35,994
Net cash used in operating activities		(189,709	)		(140,172	)

Net change in cash		(189,709	)		(140,172	)

Cash, beginning of the period		442,147			1,063,837
Cash, end of the period	$	252,438		$	923,665
Supplemental Disclosure of Cash Flow Information:
Accretion of carrying value to redemption value	$	285,612		$	2,189,543

The accompanying notes are an integral part of these unaudited condensed financial statements.

A SPAC II ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Note 1 – Description of Organization and Business Operation

A SPAC II Acquisition Corp. (the “Company”) was incorporated in the British Virgin Islands on June 28, 2021. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination.

As of March 31, 2024, the Company had not commenced any operations. All activities from June 28, 2021 (inception) through March 31, 2024, are related to the Company’s formation, the initial public offering (“IPO”) and its search of a Business Combination target as described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO (as defined below). The Company has selected December 31 as its fiscal year end.

The registration statement for the Company’s IPO became effective on May 2, 2022. On May 5, 2022, the Company consummated the IPO of 20,000,000 units (the “Units”), which includes the partial exercise of the over-allotment option of 1,500,000 Units granted to the underwriters. The Units were sold at an offering price of $10.00 per unit, generating gross proceeds of $200,000,000. Simultaneously with the closing of the IPO, the Company consummated the private placement (“Private Placement”) with A SPAC II (Holdings) Corp., the Company’s sponsor, of 8,966,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant, generating total proceeds of $8,966,000.

Transaction costs amounted to $13,150,218, consisting of $3,380,000 of underwriting fees, $7,000,000 of deferred underwriting fees (payable only upon completion of a Business Combination), $567,629 of other offering costs and $2,202,589 fair value of the 300,000 representative shares considered as part of the transaction costs.

The Company also issued 300,000 shares of Class A ordinary shares (the “Representative Shares”) to Maxim Group LLC, (“Maxim”), the representative of the underwriters, as part of representative compensation, the fair value of which is $2,202,589. The Representative Shares are identical to the public shares except that Maxim has agreed not to transfer, assign or sell any such representative shares until the completion of the Company’s initial Business Combination. The Representative Shares are deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the date of the commencement of sales in this offering pursuant to FINRA Rule 5110(e)(1). In addition, the representatives have agreed (i) to waive their redemption rights with respect to such shares in connection with the completion of the Company’s initial Business Combination and (ii) to waive their rights to liquidating distributions from the Trust Account (as defined below) with respect to such shares if the Company fails to complete its initial Business Combination within 15 months of the closing of the IPO (or 21 months, if the Company extends the time to complete a Business Combination).

Upon the closing of the IPO on May 5, 2022, $203,500,000 ($10.175 per Unit) from the net offering proceeds of the sale of the Units in the IPO and a portion of the sale of the Private Placement was placed in a trust account (the “Trust Account”) maintained by Continental Stock Transfer& Trust as a trustee and will be invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.

The Company will provide the holders of the outstanding Class A ordinary shares sold with the Units (the “Public Shares”) sold in the IPO (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.175 per Public Share, plus any pro rata interest then in the Trust Account, net of taxes payable).

All of the Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a shareholder vote or tender offer in connection with the Company’s Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation (the “Certificate of Incorporation”). In accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480 “Distinguishing Liabilities from Equity” (“ASC 480”) Subtopic 10-S99, redemption provisions not solely within the control of a company require Class A Ordinary Shares subject to redemption to be classified outside of permanent equity. Given that the Public Shares will be issued with other freestanding instruments (i.e., Public Warrants and Public Rights), the initial carrying value of Class A Ordinary Shares classified as temporary equity will be the allocated proceeds determined in accordance with ASC 470-20 “Debt with Conversion and other Options”. The Class A Ordinary Shares are subject to ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. While redemptions in connection with our initial business combination cannot cause the Company’s net tangible assets to fall below $5,000,001, the Public Shares are redeemable and will be classified as such on the balance sheet until such date that a redemption event takes place.

Redemptions of the Company’s Public Shares may be subject to the satisfaction of conditions, including minimum cash conditions, pursuant to an agreement relating to the Company’s Business Combination. If the Company seeks shareholder approval of the Business Combination, the Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination, or such other vote as required by law or stock exchange rule. If a shareholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its Certificate of Incorporation, conduct the redemptions pursuant to the tender offer rules of the Securities Exchange Commission (the “SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transaction is required by applicable law or stock exchange listing requirements, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 4) and any Public Shares purchased during or after the IPO in favor of approving a Business Combination. Additionally, each Public Shareholder may elect to redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction.

The Company’s Sponsor, officers and directors (the “Initial Shareholder”) has agreed not to propose an amendment to the Certificate of Incorporation that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment.

If the Company is unable to complete a Business Combination within 15 months from the closing of the IPO (the “Combination Period”) (or up to 21 months from the closing of this offering if the Company extends the period of time to consummate a Business Combination) , the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its franchise and income taxes (less up to $50,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s Board of Directors, dissolve and liquidate, subject in each case to the Company’s obligations under British Virgin Islands law to provide for claims of creditors and the requirements of other applicable law.

The Initial Shareholder have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Shareholders should acquire Public Shares in or after the IPO, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

On August 1, 2023, at its Extraordinary General Meeting (the “EGM”), the Company’s shareholders approved a proposal to amend and restate the Company’s Amended and Restated Memorandum and Articles of Association (“the Charter”) to, among other things, allow the Company to extend the date by which it has to complete a business combination to August 5, 2024, or up to 27 months from its initial public offering. In connection with the shareholders’ vote at the EGM, 18,003,605 Class A ordinary shares with redemption value of $190,703,967 were tendered for redemption on August 1, 2023. The Company filed the Charter amendment with the Registrar of Corporate Affairs at the British Virgin Islands on August 1, 2023.

On December 11, 2023, the Company received a notice from Nasdaq, stating that the Company’s listed securities failed to comply with the $50,000,000 market value of listed securities requirement for continued listing on the Nasdaq Global Market in accordance with Nasdaq Listing Rule 5450(b)(2)(A) based upon the Company’s market value of listed securities for the 30 consecutive business days prior to the date of the notice. Pursuant to a Share Exchange Agreement entered by and between the Company and the Sponsor dated December 7, 2023, the Sponsor has transferred and delivered to the Company 4,900,000 Class B ordinary shares of the Company in exchange for 4,900,000 Class A ordinary shares of the Company (the “Share Exchange”). The 4,900,000 Class A Shares issued in connection with the Share Exchange are subject to the same restricted as applied to the Class B Shares before the Share Exchange, including, among other things, certain transfer restrictions, waiver of redemption rights and the obligation to vote in favor of an initial business combination as described in the prospectus for the Company’s initial public offering.

Following the Share Exchange, there are 7,196,395 Class A ordinary shares and 100,000 Class B ordinary shares issued and outstanding. As a result of the Share Exchange, the Sponsor holds approximately 68.1% of the Company’s outstanding Class A ordinary shares. The issuance of the 4,900,000 Class A ordinary shares has not been registered under the Securities Act of 1933, as amended, in reliance on the exemption from registration provided by Section 3(a)(9) thereof.

On March 15, 2024, the Company received a letter from The Nasdaq Stock Market LLC (“Nasdaq”), which stated that the Company no longer complies with Nasdaq’s continued listing rules on The Nasdaq Global Market due to the Company not having maintained a minimum of 400 public holders for continued listing, as required pursuant to Nasdaq Listing Rule 5450(a)(2). In accordance with the Nasdaq listing rules, the Company has 45 calendar days to submit a plan to regain compliance. On April 29, 2024, the Company submitted a compliance plan. On May 1, 2024, the Company received a letter from Nasdaq accepting the Company’s compliance plan. The Company has been given an extension of up to September 11, 2024 to regain compliance with Rule 5450(a)(2). In the event that the Company does not regain compliance on or before September 11, 2024, Nasdaq will provide notice to the Company that its listed securities will be delisted and at that time, the Company may appeal the determination to the Nasdaq Listing Qualifications Panel.

Going Concern Consideration

As of March 31, 2024, the Company had cash of $252,438 and a working capital of $176,015.

The Company has until August 5, 2024 to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution.

The Company has incurred and expects to continue to incur significant professional costs to remain as a publicly traded company and to incur significant transaction costs in pursuit of the consummation of a Business Combination. The Company may need to obtain additional financing either to complete its Business Combination or because it becomes obligated to redeem a significant number of public shares upon consummation of its Business Combination, in which case, subject to compliance with applicable securities laws, the Company may issue additional securities or incur debt in connection with such Business Combination. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that these conditions raise substantial doubt about the Company’s ability to continue as a going concern. In addition, if the Company is unable to complete a Business Combination within the Combination Period (by August 5, 2024), the Company’s board of directors would proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company. There is no assurance that the Company’s plans to consummate a Business Combination will be successful within the Combination Period. As a result, management has determined that such an additional condition also raises substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Risks and Uncertainties

The Company continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that COVID-19 could have a negative effect on the Company’s search for a target company for a Business Combination, the specific impact is not readily determinable as of the date of these unaudited condensed financial statements. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Additionally, as a result of the military action commenced in February 2022 by the Russian Federation and Belarus in the country of Ukraine and related economic sanctions and the impact of armed conflict in Israel and the Gaza Strip commenced in October 2023, the Company’s ability to consummate a Business Combination, or the operations of a target business with which the Company ultimately consummates a Business Combination, may be materially and adversely affected. In addition, the Company’s ability to consummate a transaction may be dependent on the ability to raise equity and debt financing which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity in third-party financing being unavailable on terms acceptable to the Company or at all. The impact of this action and related sanctions on the world economy and the specific impact on the Company’s financial position, results of operations and/or ability to consummate a Business Combination are not yet determinable. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Note 2 – Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed financial statements are presented in U.S. Dollars and in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. Accordingly, they include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. The interim results for the three months ended March 31, 2024 are not necessarily indicative of the results that may be expected through December 31, 2024 or for any future periods.

Emerging Growth Company

The Company is an “emerging growth company” as defined in Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of unaudited condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.

Investment Held in Trust Account

The Company’s portfolio of investments held in the Trust Account is comprised of investments in money market funds that invest in U.S. government securities. These securities are presented on the balance sheet at fair value at the end of each reporting period. Earnings on investments held in the Trust Account are included in interest earned on investments held in the Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair value of investments held in the Trust Account is determined using available market information.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $252,438 and $442,147 in cash as of March 31, 2024 and December 31, 2023, respectively. The Company did not have any cash equivalents as of March 31, 2024 and December 31, 2023.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition. As of March 31, 2024 and December 31, 2023, the Company has not experienced losses on this account.

Class A Ordinary Shares Subject to Possible Redemption

The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of March 31, 2024 and December 31, 2023, shares of common stock subject to possible redemption are presented at redemption value of $11.111 and $10.968 per share, respectively, as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of shares of redeemable common stock are affected by charges against additional paid in capital or accumulated deficit if additional paid in capital equals to zero.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.

Warrant Instruments

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the instruments’ specific terms and applicable authoritative guidance in ASC 480 and ASC 815, “Derivatives and Hedging” (“ASC 815”). The assessment considers whether the instruments are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the instruments meet all of the requirements for equity classification under ASC 815, including whether the instruments are indexed to the Company’s own ordinary shares and whether the instrument holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the instruments are outstanding. As discussed in Note 7, the Company determined that upon further review of the warrant agreement, management concluded that the Public Warrants (as defined in Note 3) and Private Placement Warrants issued pursuant to the warrant agreement qualify for equity accounting treatment.

Net Income (Loss) Per Share

The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The condensed statements of operations include a presentation of income (loss) per redeemable share and income (loss) per non-redeemable share following the two-class method of income per share. In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net loss less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption value of the common shares subject to possible redemption was considered to be dividends paid to the public shareholders. As of March 31, 2024 and 2023, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented.

The net income (loss) per share presented in the statement of operations is based on the following:

	For the Three Months Ended March 31,
	2024			2023
Net income	$	142,345		$	2,002,044
Accretion of ordinary shares to redemption value		(285,612	)		(2,189,543	)
Net loss including accretion of ordinary shares to redemption value	$	(143,267	)	$	(187,499	)

	For the Three Months Ended March 31,
	2024						2023
	Redeemable Class A Ordinary Shares			Non-redeemable Class A and Class B Ordinary Shares			Redeemable Class A Ordinary Shares			Non-redeemable Class A and Class B Ordinary Shares
Basic and diluted net income (loss) per ordinary share
Numerator:
Allocation of net loss	$	(39,200	)	$	(104,067	)	$	(150,444	)	$	(37,055	)
Accretion of ordinary shares subject to possible redemption to redemption value		285,612			—			2,189,543			—
Allocation of net income (loss)		246,412			(104,067	)		2,039,099			(37,055	)

Denominator:
Basic and diluted weighted average shares outstanding		1,996,395			5,300,000			20,300,000			5,000,000
Basic and diluted net income (loss) per ordinary share	$	0.12		$	(0.02	)	$	0.10		$	(0.01	)

Income Taxes

The Company complies with the accounting and reporting requirements of ASC 740, “Income Taxes,” (“ASC 740”) which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2024. The Company’s management determined that the British Virgin Islands is the Company’s only major tax jurisdiction. The Company is not currently aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. There is currently no taxation imposed by the Government of the British Virgin Islands. In accordance with British Virgin Islands income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

Recent Accounting Pronouncements

In December 2023, the FASB issued Accounting Standards Update 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosure” (“ASU 2023-09”). ASU 2023-09 mostly requires, on an annual basis, disclosure of specific categories in an entity’s effective tax rate reconciliation and income taxes paid disaggregated by jurisdiction. The incremental disclosures may be presented on a prospective or retrospective basis. The ASU is effective for fiscal years beginning after December 15, 2024 with early adoption permitted. The Company is currently assessing the impact, if any, that ASU 2023-09 would have on its financial position, results of operations or cash flows.

The Company’s management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

Note 3 – Initial Public Offering

Pursuant to the IPO on May 5, 2022, the Company sold 20,000,000 Units at a price of $10.00 per Unit. Each Unit consists of one Class A Ordinary Share, one-half of one redeemable warrant (“Public Warrant”), and one right to receive one-tenth (1/10) of one Class A ordinary share at the closing of the Company’s Business Combination (“Public Right”).

All of the 20,000,000 Public Shares sold as part of the Units in the IPO contain a redemption feature which allows for the redemption of such Public Shares if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation, or in connection with the Company’s liquidation. In accordance with the SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require common stock subject to redemption to be classified outside of permanent equity. If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. The accretion or remeasurement is treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital).

As of March 31, 2024 and December 31, 2023, the Class A Ordinary share reflected on the balance sheet are reconciled in the following table.

Gross proceeds from IPO	$	200,000,000
Less:
Proceeds allocated to Public Warrants and Public Rights		(15,500,000	)
Proceeds allocate to over-allotment liability		(67,450	)
Class A ordinary shares issuance cost		(12,109,127	)
Plus:
Remeasurement of carrying value to redemption value		34,032,804
Class A Ordinary shares subject to possible redemption - December 31, 2022		206,356,227
Plus:
Remeasurement of carrying value to redemption value		6,243,425
Less:
Payment to redeemed shareholders		(190,703,967	)
Class A Ordinary shares subject to possible redemption- December 31, 2023		21,895,685
Plus:
Remeasurement of carrying value to redemption value		285,612
Class A Ordinary shares subject to possible redemption- March 31, 2024	$	22,181,297

Note 4 – Private Placement Warrants

Simultaneously with the closing of the IPO, the Sponsor purchased an aggregate of 8,966,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $8,966,000. The Private Placement Warrants are identical to the Public Warrants sold in the IPO, except with respect to certain registration rights and transfer restrictions. The proceeds from the Private Placement Warrants were added to the proceeds from the IPO to be held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Warrants and all underlying securities will expire worthless.

Note 5 – Related Party Transactions

Founder Shares

On June 28, 2021, the Sponsor purchased 5,750,000 shares (the “Founder Shares”) of the Company’s Class B Ordinary Shares, with no par value (“Class B Ordinary Shares”) for an aggregate price of $25,000. On March 24, 2022, the Company cancelled 431,250 of such founder shares for no consideration, resulting in 5,318,750 founder shares remaining outstanding (of which an aggregate of up to 693,750 shares are subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter).

The Initial Shareholders have agreed to forfeit up to 693,750 Founder Shares to the extent that the over-allotment option is not exercised in full by the underwriters. The forfeiture will be adjusted to the extent that the over-allotment option is not exercised in full by the underwriters so that the Founder Shares will represent 20.0% of the Company’s issued and outstanding shares after the IPO. As a result of the underwriter’s partial exercise of the over-allotment option on May 5, 2022, 318,750 shares of Class B ordinary share were forfeited for no consideration on May 6, 2022.

Pursuant to a Share Exchange Agreement entered by and between the Company and the Sponsor dated December 7, 2023, the Sponsor has transferred and delivered to the Company 4,900,000 Class B ordinary shares of the Company in exchange for 4,900,000 Class A ordinary shares of the Company (the “Share Exchange”). The 4,900,000 Class A Shares issued in connection with the Share Exchange are subject to the same restricted as applied to the Class B Shares before the Share Exchange, including, among other things, certain transfer restrictions, waiver of redemption rights and the obligation to vote in favor of an initial business combination as described in the prospectus for the Company’s initial public offering.

Following the Share Exchange, there were 7,196,395 Class A ordinary shares and 100,000 Class B ordinary shares issued and outstanding. As a result of the Share Exchange, the Sponsor holds approximately 68.1% of the Company’s outstanding Class A ordinary shares. The issuance of the 4,900,000 Class A ordinary shares has not been registered under the Securities Act of 1933, as amended, in reliance on the exemption from registration provided by Section 3(a)(9) thereof.

The Initial Shareholders will agree, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) six months after the completion of the initial Business Combination or (B) subsequent to the initial Business Combination, (x) if the last sale price of the Class A Ordinary Shares equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Company’s shareholders having the right to exchange their ordinary shares for cash, securities or other property.

Promissory Note - Related Party

On July 8, 2021, the Sponsor agreed to loan the Company an aggregate of up to $400,000 to cover expenses related to the IPO pursuant to a promissory note (the “Note”). This loan is non-interest bearing and payable on the earlier of March 31, 2022 or the completion of the IPO. The amount was subsequently repaid on May 10, 2022. As of March 31, 2024 and December 31, 2023, there were no borrowings outstanding under the Note.

Working Capital Loans

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,150,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. As of March 31, 2024 and December 31, 2023, there were no Working Capital Loans outstanding.

Note 6 – Commitments & Contingencies

Registration & Shareholder Rights

The holders of the Founder Shares, the Private Placement Warrants, and any warrants that may be issued in payment of Working Capital Loans (and all underlying securities) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the IPO requiring the Company to register such securities for resale. The holders of a majority of these securities are entitled to make up to three demands that the Company register such securities. The holders of the majority of the Founders Shares can elect to exercise these registration rights at any time commencing three months prior to the date on which these ordinary shares are to be released from escrow. The holders of a majority of the Private Placement Warrants and securities issued in payment of Working Capital Loans can elect to exercise these registration rights at any time commencing on the date that the Company consummates a Business Combination. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination. Notwithstanding the foregoing, the underwriter may not exercise its demand and “piggyback” registration rights after five (5) and seven (7) years, respectively, after the effective date of the IPO and may not exercise its demand rights on more than one occasion. The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The Company granted Maxim, the representative of the underwriters a 45-day option from the date of the IPO to purchase up to 2,775,000 additional Units to cover over-allotments, if any, at IPO price less the underwriting discounts and commissions. On May 5, 2022, simultaneously with the closing of the IPO, the underwriter partially exercised its over-allotment option to purchase 1,500,000 Units, generating gross proceeds to the Company of $15,000,000.

The underwriters were paid a cash underwriting discount of $0.169 per unit, or $ 3,380,000 (including the partial exercise of over-allotment option) upon the closing of the IPO. In addition, the underwriters will be entitled to a deferred commission of $0.35 per unit, or $7,000,000 (including the over-allotment of 1,500,000 units), which will be paid upon the closing of a Business Combination from the amounts held in the Trust Account, subject to the terms of the underwriting agreement.

Representative’s Class A Ordinary Shares

The Company issued to Maxim and/or its designees, 300,000 Class A ordinary shares including 22,500 shares as a result of partial exercise of the underwriters’ over-allotment option at the closing of the IPO.

The shares have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the date of the commencement of sales in this offering pursuant to FINRA Rule 5110(e)(1). Pursuant to FINRA Rule 5110(e)(1), these securities will not be the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person for a period of 180 days immediately following the effective date of the registration statement of which this prospectus forms a part, nor may they be sold, transferred, assigned, pledged or hypothecated for a period of 180 days immediately following the effective date of the registration statement of which this prospectus forms a part except to any underwriter and selected dealer participating in the offering and their officers, partners, registered persons or affiliates.

The representative’s ordinary shares are measured at fair value upon the issue date. The Company used both Monte Carlo model and Probability-Weighted Expected Return Method that values the representative shares. Key inputs into the Monte Carlo model were (i) risk-free rate of 2.14%, (ii) volatility of 2.1%, (iii) estimated term of 1.10 years, resulting in the fair value of the 300,000 representative shares of approximately $2,202,589 or $7.34 per share.

Note 7—Shareholders’ Deficit

Ordinary shares

Preference shares—The Company is authorized to issue 1,000,000 shares of preference shares with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s Board of Directors. As of March 31, 2024 and December 31, 2023, there were no shares of preference shares issued or outstanding.

Class A Ordinary shares—The Company is authorized to issue 500,000,000 shares of Class A Ordinary shares with no par value. As of March 31, 2024 and December 31, 2023, there were 5,200,000 shares of Class A Ordinary Shares outstanding (excluding 1,996,395 subject to possible redemption).

Class B Ordinary shares—The Company is authorized to issue 50,000,000 shares of Class B Ordinary shares with no par value. Holders of Class B Ordinary shares are entitled to one vote for each share. On March 24, 2022, the Company canceled 431,250 of such founder shares for no consideration, resulting in 5,318,750 founder shares remaining outstanding (of which an aggregate of up to 693,750 shares are subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter). As a result of the underwriter’s partial exercise of the over-allotment option on May 5, 2022, 318,750 shares of Class B Ordinary share were forfeited for no consideration on May 6, 2022.

On December 7, 2023, 4,900,000 Class B Ordinary shares were exchanged for 4,900,000 Class A Ordinary shares of the Company (the “Share Exchange”) pursuant to a Share Exchange Agreement between the Company and the Sponsor. The 4,900,000 Class A ordinary shares issued in connection with the Share Exchange are subject to the same restricted as applied to the Class B ordinary shares before the Share Exchange, including, among other things, certain transfer restrictions, waiver of redemption rights and the obligation to vote in favor of an initial business combination as described in the prospectus for the Company’s initial public offering. As a result of the Share Exchange, the Sponsor holds approximately 68.1% of the Company’s outstanding Class A Ordinary shares.

As of March 31, 2024 and December 31, 2023, there were 7,196,395 Class A Ordinary shares and 100,000 Class B Ordinary shares issued and outstanding.

Holders of Class A Ordinary shares and Class B Ordinary shares will vote together as a single class on all other matters submitted to a vote of stockholders except as required by law.

The Class B Ordinary shares will automatically convert into Class A Ordinary shares at the time of the initial Business Combination on a one-for-one basis, subject to adjustment. In the case that additional Class A Ordinary Shares, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in the Proposed Public Offering and related to the closing of the initial Business Combination, the ratio at which Class B Ordinary shares shall convert into Class A Ordinary Shares will be adjusted (unless the holders of a majority of the outstanding Class B Ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A Ordinary shares issuable upon conversion of all Class B Ordinary shares will equal, in the aggregate, on an as-converted basis, 20.0% of the sum of the total number of all Ordinary Shares outstanding upon the completion of the IPO (excluding the Private Placement Warrants purchased by the Sponsor) plus all Class A Ordinary shares and equity-linked securities issued or deemed issued in connection with the initial Business Combination. Holders of Founder Shares may also elect to convert their Class B Ordinary shares into an equal number of shares of Class A Ordinary shares, subject to adjustment as provided above, at any time.

Warrants— Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as discussed below. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Company will account for the Private Placement Warrants as equity instruments. The Public Warrants will become exercisable on the later of the completion of a Business Combination and twelve months from the effective date of this registration statement. No warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the ordinary shares issuable upon exercise of the Warrants and a current prospectus relating to such ordinary shares. Notwithstanding the foregoing, if a registration statement covering the Class A ordinary shares issuable upon exercise of the Public Warrants is not effective within a specified period following the consummation of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise Pubic Warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their Public Warrants on a cashless basis. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. There were 9,999,989 Public Warrants outstanding as of March 31, 2024 and December 31, 2023.

Redemption of warrants when the price per ordinary shares equals or exceeds $16.50.

Once the Warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):

in whole and not in part;

●

at a price of $0.01 per Warrant;

●

upon a minimum of 30 days’ prior written notice of redemption, which the Company refers to as the “30-day redemption period”; and

●

if, and only if, the last reported sale price (the “closing price”) of our ordinary shares equals or exceeds $16.50 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities—Warrants—Public shareholders’ Warrants—Anti-Dilution Adjustments”) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.

The Company will not redeem the Warrants as described above unless an effective registration statement under the Securities Act covering the ordinary shares issuable upon exercise of the warrants is effective and a current prospectus relating to those ordinary shares is available throughout the 30-day redemption period.

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement.

The exercise price and number of Class A ordinary shares issuable on exercise of the warrants may be adjusted in certain circumstances including in the event of a share splits, share capitalization, share dividends, reorganizations, recapitalizations and the like. However, the Warrants will not be adjusted for issuances of Class A ordinary shares at a price below their respective exercise prices. Additionally, in no event will the Company be required to net cash settle the Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the Warrants may expire worthless.

In addition, if the Company issues additional Class A Ordinary Shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of ordinary shares (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the Initial Shareholders or their affiliates, without taking into account any Founder Shares held by them prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A Ordinary Shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii) the Newly Issued Price, and the $16.50 share redemption trigger price described below under “Description of Securities — Redeemable Warrants” will be adjusted (to the nearest cent) to be equal to 165% of the higher of the Market Value and the Newly Issued Price.

The Private Placement Warrants will be identical to the Public Warrants underlying the Units being sold in the Proposed Public Offering, except that the Private Placement Warrants and the Class A ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or saleable until 30 days after the completion of a Business Combination, subject to certain limited exceptions.

Rights—Except in cases where the Company is not the surviving company in a Business Combination, each holder of a Public Right will automatically receive one-tenth (1/10) of one Class A ordinary share upon consummation of a Business Combination, even if the holder of a Public Right converted all shares held by him, her or it in connection with a Business Combination or an amendment to the Company’s Certificate of Incorporation with respect to its pre-business combination activities. In the event that the Company will not be the surviving company upon completion of a Business Combination, each holder of a Public Right will be required to affirmatively convert his, her or its rights in order to receive the one-tenth (1/10) of one Class A ordinary share underlying each Public Right upon consummation of the Business Combination. No additional consideration will be required to be paid by a holder of Public Rights in order to receive his, her or its additional Class A ordinary shares upon consummation of a Business Combination. The shares issuable upon exchange of the rights will be freely tradable (except to the extent held by affiliates of the Company). If the Company enters into a definitive agreement for a Business Combination in which the Company will not be the surviving entity, the definitive agreement will provide for the holders of Public Rights to receive the same per share consideration the holders of the Class A ordinary shares will receive in the transaction on an as-converted into ordinary shares basis.

The Company will not issue fractional shares in connection with an exchange of Public Rights. Fractional shares will either be rounded down to the nearest whole share or otherwise addressed in accordance with the applicable provisions of the British Virgin Islands General Corporation Law. As a result, the holders of the Public Rights must hold rights in multiples of 10 in order to receive shares for all of the holders’ rights upon closing of a Business Combination. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Rights will not receive any of such funds with respect to their Public Rights, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Rights, and the Public Rights will expire worthless. Further, there are no contractual penalties for failure to deliver securities to the holders of the Public Rights upon consummation of a Business Combination. Additionally, in no event will the Company be required to net cash settle the rights. Accordingly, the rights may expire and become worthless. There were 20,000,000 Public Rights outstanding as of March 31, 2024 and December 31, 2023.

Note 8—Fair Value Measurements

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

Level 1:

Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

Level 2:

Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

Level 3:

Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of March 31, 2024 and December 31, 2023 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.

	March 31,		Quoted Prices in Active Markets		Significant Other Observable Inputs		Significant Other Unobservable Inputs
	2024		(Level 1)		(Level 2)		(Level 3)
Assets
Marketable securities held in Trust Account	$	22,181,297	$	22,181,297		—		—

	December 31,		Quoted Prices in Active Markets		Significant Other Observable Inputs		Significant Other Unobservable Inputs
	2023		(Level 1)		(Level 2)		(Level 3)
Assets
Marketable securities held in Trust account	$	21,895,685	$	21,895,685		—		—

The following table presents information about the Company’s equity instrument that are measured at fair value on a non-recurring basis as of May 5, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

	May 5,
	2022		Level
Equity instrument:
Representative shares	$	2,202,589		3

The Company used several models (i.e., Monte Carlo, PWERM and Finnerty) to value the Representative Shares granted to Maxim. Key inputs into the Monte Carlo model were (i) risk-free rate of 2.14%, (ii) volatility of 2.1%, (iii) estimated term of 1.10 years, resulting in the fair value of the 300,000 representative shares being approximately $2,202,589 or $7.34 per share.

Note 9 – Subsequent Events

In accordance with ASC 855, “Subsequent Events”, the Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the unaudited condensed financial statement was issued. Based on this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statement.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

References to the “Company,” “ASCB,” “our,” “us” or “we” refer to A SPAC II Acquisition Corp. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other U.S. Securities and Exchange Commission (“SEC”) filings.

Overview

We are a blank check company incorporated in the British Virgin Islands as a business company and incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (“Business Combination”). We have not yet selected any specific Business Combination target. We intend to effectuate our initial Business Combination using cash from the proceeds of the initial public offering (the “IPO”) and the private placement of the private placement warrants (the “Private Placement”), the proceeds of the sale of our securities in connection with our initial Business Combination, our shares, debt or a combination of cash, stock and debt.

We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.

Recent Developments

On December 11, 2023, the Company received a notice from Nasdaq, stating that the Company’s listed securities failed to comply with the $50,000,000 market value of listed securities requirement (the “MVLS Requirement”) for continued listing on the Nasdaq Global Market in accordance with Nasdaq Listing Rule 5450(b)(2)(A) based upon the Company’s market value of listed securities for the 30 consecutive business days prior to the date of the notice. Pursuant to a Share Exchange Agreement between the Company and the Sponsor dated December 7, 2023, the Sponsor has transferred and delivered to the Company 4,900,000 Class B ordinary shares of the Company in exchange for 4,900,000 Class A ordinary shares of the Company (the “Share Exchange”). Following the Share Exchange, there are 7,196,395 Class A ordinary shares and 100,000 Class B ordinary shares issued and outstanding. Therefore, the Company believes that it has regained compliance with the MVLS Requirement.

On March 15, 2024, the Company received a letter from Nasdaq, which stated that the Company no longer complies with Nasdaq’s continued listing rules on The Nasdaq Global Market due to the Company not having maintained a minimum of 400 public holders for continued listing, as required pursuant to Nasdaq Listing Rule 5450(a)(2). The Company has 45 calendar days to submit a plan to regain compliance. On April 29, 2024, the Company submitted a compliance plan. On May 1, 2024, the Company received a letter from Nasdaq accepting the Company’s compliance plan. The Company has been given an extension of up to September 11, 2024 to regain compliance with Rule 5450(a)(2). In the event that the Company does not regain compliance on or before September 11, 2024, Nasdaq will provide notice to the Company that its listed securities will be delisted and at that time, the Company may appeal the determination to the Nasdaq Listing Qualifications Panel.

Results of Operations

We have neither engaged in any operations nor generated any operating revenues to date. Our only activities from inception June 28, 2021 (inception) through March 31, 2024 were organizational activities and those necessary to prepare for, and consummate, the IPO. Following our IPO, our only activities have been seeking a target business with which to complete a business combination. We do not expect to generate any operating revenue until after the completion of our initial Business Combination.

We expect to continue to generate non-operating income in the form of interest income on marketable securities held after the IPO. We expect that we will continue to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with searching for, and completing, a Business Combination.

For the three months ended March 31, 2024, we had a net income of $142,345, which consisted of general and administrative expenses of $148,651, offset by interest income of $290,996.

For the three months ended March 31, 2023, we had a net income of $2,002,044, which consisted of general and administrative expenses of $197,239, offset by interest income of $2,199,283.

Liquidity and Capital Resources

As previously disclosed on a Current Report on Form 8-K filed on May 6, 2022, the Company consummated the IPO of 20,000,000 units (the “Units”) which includes the partial exercise of the over-allotment option granted to the underwriters. Each Unit consists of one ordinary share (“Ordinary Share”), one-half of one redeemable warrant (“Warrant”) entitling its holder to purchase one Ordinary Share at a price of $11.50 per full share and one right (“Right”) to receive one-tenth of one Class A ordinary share upon the consummation of an initial Business Combination. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $200,000,000.

Simultaneously with the closing of the IPO, the Company consummated the Private Placement with the Company’s Sponsor of 8,966,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, generating total proceeds of $8,966,000. The Private Placement Warrants are identical to the public warrants sold in the IPO, as set forth in the Underwriting Agreement, except as described in the Warrant Agreement.

On May 5, 2022, a total of $203,500,000 of the net proceeds from the IPO and the Private Placement were deposited in a Trust Account established for the benefit of the Company’s public shareholders. We intend to use substantially all of the funds held in the Trust Account, to acquire a target business and to pay our expenses relating thereto. To the extent that our capital stock is used in whole or in part as consideration to effect a Business Combination, the remaining funds held in the Trust Account will be used as working capital to finance the operations of the target business. Such working capital funds could be used in a variety of ways including continuing or expanding the target business’ operations, for strategic acquisitions and for marketing, research and development of existing or new products. Such funds could also be used to repay any operating expenses or finders’ fees which we had incurred prior to the completion of our Business Combination if the funds available to us outside of the Trust Account were insufficient to cover such expenses.

For the three months ended March 31, 2024 and 2023, cash used in operating activities was $189,709 and $140,172, respectively.

As of March 31, 2024, we had marketable securities held in the Trust Account of $22,181,297 consisting of securities held in a treasury trust fund that invests in United States government treasury bills, bonds or notes with a maturity of 185 days or less. Interest income on the balance in the Trust Account may be used by us to pay taxes. Through March 31, 2024, we did not withdraw any interest earned on the Trust Account to pay our taxes. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less taxes payable), to acquire a target business and to pay our expenses relating thereto. To the extent that our capital stock is used in whole or in part as consideration to effect a business combination, the remaining funds held in the Trust Account will be used as working capital to finance the operations of the target business. Such working capital funds could be used in a variety of ways including continuing or expanding the target business’ operations, for strategic acquisitions and for marketing, research and development of existing or new products or services. Such funds could also be used to repay any operating expenses or finders’ fees which we had incurred prior to the completion of our business combination if the funds available to us outside of the Trust Account were insufficient to cover such expenses.

As of March 31, 2024, we had cash of $252,438 outside the Trust Account. Until consummation of the Business Combination, we intend to use the funds held outside the Trust Account for identifying and evaluating prospective acquisition candidates, performing business due diligence on prospective target businesses, traveling to and from the offices, plants or similar locations of prospective target businesses, reviewing corporate documents and material agreements of prospective target businesses, selecting the target business to acquire and structuring, negotiating and consummating the Business Combination.

If our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a business combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our business combination. In this event, our officers, directors or their affiliates may, but are not obligated to, loan us funds as may be required. If we consummate an initial business combination, we would repay such loaned amounts out of the proceeds of the Trust Account released to us upon consummation of the business combination. In the event that a business combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts, but no proceeds from our Trust Account would be used for such repayment. The terms of such loans by our initial shareholders, officers and directors, if any, have not been determined and no written agreements exist with respect to such loans.

Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our public shares upon consummation of our Business Combination, in which case, subject to compliance with applicable securities laws, we may issue additional securities or incur debt in connection with such Business Combination. Subject to compliance with applicable securities laws, we would only complete such financing simultaneously with the completion of our Business Combination. If we are unable to complete our Business Combination because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the Trust Account. In addition, following our Business Combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations.

As of March 31, 2024, the Company had cash of $252,438 and working capital of $176,015. Pursuant to the Company’s Second Amended and Restated Memorandum and Articles of Association, the Company has until August 5, 2024 to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination within this time period (the “Combination Period”). If a Business Combination is not consummated within the Combination Period, there will be a mandatory liquidation and subsequent dissolution.

The Company has incurred and expects to continue to incur significant professional costs to remain as a publicly traded company and to incur significant transaction costs in pursuit of the consummation of a business combination. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that these conditions raise substantial doubt about the Company’s ability to continue as a going concern. The management’s plan in addressing this uncertainty is through the Working Capital Loans (see Note 5). In addition, if the Company is unable to complete a business combination within the Combination Period (by August 5, 2024), the Company’s board of directors would proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company. There is no assurance that the Company’s plans to consummate a business combination will be successful within the Combination Period. As a result, management has determined that such an additional condition also raises substantial doubt about the Company’s ability to continue as a going concern. The financial statement does not include any adjustments that might result from the outcome of this uncertainty.

Off-Balance Sheet Financing Arrangements

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of March 31, 2024. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non- financial assets.

Contractual Obligations

As of March 31, 2024 we did not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than described below:

Registration Rights

The holders of founder shares, private placement warrants, shares being issued to the underwriters and warrants that may be issued on conversion of working capital loans (and in each case holders of their component securities, as applicable) will be entitled to registration rights pursuant to a registration rights agreement that required the Company to register such securities for resale (in the case of the founder shares, only after conversion to our Class A ordinary shares). The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The underwriters are entitled to a deferred fee of $7,000,000 (i.e., 3.5% of the gross proceeds of the IPO and over-allotment). The deferred fee will be payable in cash to the underwriters solely in the event that we complete a Business Combination from the amounts held in the Trust Account, subject to the terms of the underwriting agreement.

Representative’s Ordinary Shares

The Company issued to the underwriters and/or its designees, 300,000 Class A ordinary shares including 22,500 ordinary shares as a result of partial exercise of the underwriters’ over-allotment option at the closing of the IPO.

Critical Accounting Estimates

We prepare our financial statements in accordance with accounting principles generally accepted in the United States of America. The preparation of financial statements also requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, costs and expenses and related disclosures. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ significantly from the estimates made by our management. We have not identified any critical accounting estimates.

Recent Accounting Standards

Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

As smaller reporting company, we are not required to make disclosures under this Item.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls are procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, such as this Report, is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and forms. Disclosure controls are also designed with the objective of ensuring that such information is accumulated and communicated to our management, including the chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure. Our management evaluated, with the participation of our current chief executive officer and chief financial officer (our “Certifying Officers”), the effectiveness of our disclosure controls and procedures as of March 31, 2024, pursuant to Rule 15d-15(e) under the Exchange Act. Based upon that evaluation, our Certifying Officers concluded that, as of March 31, 2024, our disclosure controls and procedures were effective.

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

We may be subject to legal proceedings, investigations and claims or other contingencies incidental to the conduct of our business from time to time. We are not currently a party to any material litigation or other legal proceedings brought against us. We are not aware of any legal proceeding, investigation or claim, or other legal exposure that has a more than remote possibility of having a material adverse effect on our business, financial condition or results of operations.

Item 1A. Risk Factors.

As a smaller reporting company, we are not required to make disclosures under this Item.

Item 2. Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities.

The registration statement (the “Registration Statement”) for our IPO was declared effective on May 2, 2022. As previously disclosed on a Current Report on Form 8-K dated May 6, 2022, on May 5, 2022, the Company consummated the IPO of 20,000,000 Units which includes the partial exercise of the over-allotment option granted to the underwriters. Each Unit consists of one Ordinary Share, one-half of one redeemable Warrant entitling its holder to purchase one Ordinary Share at a price of $11.50 per full share and one Right to receive one-tenth of one Ordinary Share upon the consummation of an initial Business Combination. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $200,000,000.

As previously disclosed on a Current Report on Form 8-K dated May 6, 2022, on May 5, 2022, simultaneously with the closing of the IPO, the Company consummated the Private Placement with the Company’s Sponsor of 8,966,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, generating total proceeds of $8,966,000. The Private Placement Warrants are identical to the public warrants sold in the IPO, as set forth in the Underwriting Agreement, except as described in the Warrant Agreement.

As of May 5, 2022, a total of $203,500,000 ($10.175 per Unit) of the net proceeds from the IPO and the Private Placement were deposited in a Trust Account established for the benefit of the Company’s public shareholders located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and held as cash or invested only in U.S. “government securities,” within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in money market funds meeting certain conditions under the Investment Company Act, which invest only in direct U.S. government treasury obligations, as determined by us, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.

We paid a total of approximately $3,380,000 in underwriting fees and commissions (not including the 3.5% deferred underwriting commission payable at the consummation of the initial Business Combination) and approximately $567,629 for other costs and expenses related to our formation and the IPO.

Pursuant to a Share Exchange Agreement between the Company and the Sponsor dated December 7, 2023, the Sponsor has transferred and delivered to the Company 4,900,000 Class B ordinary shares of the Company in exchange for 4,900,000 Class A ordinary shares of the Company (the “Share Exchange”). The issuance of the 4,900,000 Class A ordinary shares has not been registered under the Securities Act of 1933, as amended, in reliance on the exemption from registration provided by Section 3(a)(9) thereof.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

None.

Item 5. Other Information

None.

Item 6. Exhibits.

Exhibit Number		Description
31.1		Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to Rules 13a-14(a) and 15d- 14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2		Certification of Chief Financial Officer and Treasurer (Principal Financial and Accounting Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*		Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*		Certification of Chief Financial Officer and Treasurer (Principal Financial and Accounting Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS		Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH		Inline XBRL Taxonomy Extension Schema Document
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104		Cover Page Interactive Data File (Embedded within the Inline XBRL document and included in Exhibit)

These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: May 10, 2024	A SPAC II ACQUISITION CORP.

	By:	/s/ Serena Shie
	Name:	Serena Shie
	Title:	Chief Executive Officer
		(Principal Executive Officer)

ASPAC II Acquisition Corp. 00-0000000 20300000 1996395 0.10 0.12 5000000 5300000 0.01 0.02 20300000 1996395 5000000 5300000 0.01 0.02 0.10 0.12 false --12-31 Q1 0001876716 0001876716 2024-01-01 2024-03-31 0001876716 ascb:UnitsEachConsistingOfOneClassAOrdinaryShareWithNoParValueOnehalfOfOneRedeemableWarrantAndOneRightToReceiveOnetenthOfOneClassAOrdinaryShareMember 2024-01-01 2024-03-31 0001876716 ascb:ClassAOrdinarySharesNoParValueIncludedAsPartOfTheUnitsMember 2024-01-01 2024-03-31 0001876716 ascb:RedeemableWarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareIncludedAsPartOfTheUnitsMember 2024-01-01 2024-03-31 0001876716 ascb:RightsEachRightToReceiveOnetenth110OfOneClassAOrdinaryShareIncludedAsPartOfTheUnitsMember 2024-01-01 2024-03-31 0001876716 us-gaap:CommonClassAMember 2024-05-09 0001876716 us-gaap:CommonClassBMember 2024-05-09 0001876716 2024-03-31 0001876716 2023-12-31 0001876716 us-gaap:CommonClassAMember 2024-03-31 0001876716 us-gaap:CommonClassAMember 2023-12-31 0001876716 us-gaap:CommonClassBMember 2024-03-31 0001876716 us-gaap:CommonClassBMember 2023-12-31 0001876716 2023-01-01 2023-03-31 0001876716 ascb:OrdinarySharesSubjectToPossibleRedemptionMember 2024-01-01 2024-03-31 0001876716 ascb:OrdinarySharesSubjectToPossibleRedemptionMember 2023-01-01 2023-03-31 0001876716 ascb:ClassAAndClassBOrdinarySharesNotSubjectToRedemptionMember 2024-01-01 2024-03-31 0001876716 ascb:ClassAAndClassBOrdinarySharesNotSubjectToRedemptionMember 2023-01-01 2023-03-31 0001876716 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-12-31 0001876716 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-12-31 0001876716 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001876716 us-gaap:RetainedEarningsMember 2023-12-31 0001876716 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001876716 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001876716 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001876716 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001876716 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2024-03-31 0001876716 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2024-03-31 0001876716 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001876716 us-gaap:RetainedEarningsMember 2024-03-31 0001876716 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-12-31 0001876716 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-12-31 0001876716 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001876716 us-gaap:RetainedEarningsMember 2022-12-31 0001876716 2022-12-31 0001876716 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001876716 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001876716 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001876716 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001876716 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-03-31 0001876716 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-03-31 0001876716 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001876716 us-gaap:RetainedEarningsMember 2023-03-31 0001876716 2023-03-31 0001876716 us-gaap:IPOMember 2022-05-05 2022-05-05 0001876716 us-gaap:OverAllotmentOptionMember 2022-05-05 2022-05-05 0001876716 us-gaap:IPOMember 2022-05-05 0001876716 us-gaap:PrivatePlacementMember 2022-05-05 0001876716 us-gaap:PrivatePlacementMember 2022-05-05 2022-05-05 0001876716 ascb:MaximGroupLLCMember 2024-03-31 0001876716 2023-08-01 0001876716 us-gaap:CommonClassAMember 2023-08-01 0001876716 2023-12-11 2023-12-11 0001876716 us-gaap:CommonClassBMember 2024-01-01 2024-03-31 0001876716 us-gaap:CommonClassAMember 2024-01-01 2024-03-31 0001876716 ascb:SponsorMember us-gaap:CommonClassAMember 2024-01-01 2024-03-31 0001876716 ascb:RedeemableClassAOrdinarySharesMember 2024-01-01 2024-03-31 0001876716 ascb:NonredeemableClassAAndClassBOrdinarySharesMember 2024-01-01 2024-03-31 0001876716 ascb:RedeemableClassAOrdinarySharesMember 2023-01-01 2023-03-31 0001876716 ascb:NonredeemableClassAAndClassBOrdinarySharesMember 2023-01-01 2023-03-31 0001876716 us-gaap:IPOMember 2024-01-01 2024-03-31 0001876716 us-gaap:IPOMember 2024-03-31 0001876716 ascb:OrdinarySharesSubjectToPossibleRedemptionMember 2022-01-01 2022-12-31 0001876716 ascb:OrdinarySharesSubjectToPossibleRedemptionMember 2021-12-31 0001876716 ascb:OrdinarySharesSubjectToPossibleRedemptionMember 2023-01-01 2023-12-31 0001876716 ascb:OrdinarySharesSubjectToPossibleRedemptionMember 2023-12-31 0001876716 ascb:OrdinarySharesSubjectToPossibleRedemptionMember 2024-03-31 0001876716 ascb:PrivatePlacementWarrantsMember 2024-03-31 0001876716 ascb:PrivatePlacementWarrantsMember 2024-01-01 2024-03-31 0001876716 ascb:FounderSharesMember ascb:SponsorMember 2021-06-28 2021-06-28 0001876716 us-gaap:CommonClassBMember ascb:FounderSharesMember 2021-06-28 2021-06-28 0001876716 2022-03-01 2022-03-24 0001876716 2022-05-05 2022-05-05 0001876716 ascb:SponsorMember us-gaap:CommonClassBMember 2023-12-07 2023-12-07 0001876716 ascb:SponsorMember us-gaap:CommonClassAMember 2023-12-07 2023-12-07 0001876716 ascb:FounderSharesMember us-gaap:CommonClassAMember 2023-12-07 2023-12-07 0001876716 ascb:FounderSharesMember us-gaap:CommonClassAMember 2024-01-01 2024-03-31 0001876716 2021-07-08 2021-07-08 0001876716 us-gaap:OverAllotmentOptionMember 2022-05-05 0001876716 us-gaap:OverAllotmentOptionMember 2024-01-01 2024-03-31 0001876716 us-gaap:CommonClassAMember us-gaap:OverAllotmentOptionMember 2024-03-31 0001876716 us-gaap:WarrantMember 2024-03-31 0001876716 ascb:OrdinarySharesMember 2024-03-31 0001876716 us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001876716 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001876716 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001876716 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001876716 us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001876716 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001876716 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001876716 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001876716 us-gaap:FairValueInputsLevel3Member 2022-05-05 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure

Exhibit 31.1

CERTIFICATION

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Serena Shie, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 of A SPAC II Acquisition Corp;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: May 10, 2024	By:	/s/ Serena Shie
		Serena Shie
		Chief Executive Officer
		(Principal Executive Officer)

Exhibit 31.2

CERTIFICATION

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Claudius Tsang, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 of A SPAC II Acquisition Corp.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

5.	The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: May 10, 2024	By:	/s/ Claudius Tsang
		Claudius Tsang
		Chief Financial Officer
		(Principal Financial and Accounting Officer)

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of A SPAC II Acquisition Corp. (the “Company”) on Form 10-Q for the quarter ended March 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Serena Shie, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)	the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 10, 2024		/s/ Serena Shie
	Name:	Serena Shie
	Title:	Chief Executive Officer
		(Principal Executive Officer)

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of A SPAC II Acquisition Corp. (the “Company”) on Form 10-Q for the quarter ended March 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Claudius Tsang, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)	the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 10, 2024		/s/ Claudius Tsang
	Name:	Claudius Tsang
	Title:	Chief Financial Officer
		(Principal Financial and Accounting Officer)

Cover - shares	3 Months Ended
Cover - shares	Mar. 31, 2024	May 09, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Amendment Flag	false
Document Period End Date	Mar. 31, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Entity Information [Line Items]
Entity Registrant Name	ASPAC II Acquisition Corp.
Entity Central Index Key	0001876716
Entity File Number	001-41372
Entity Tax Identification Number	00-0000000
Entity Incorporation, State or Country Code	D8
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Shell Company	true
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Contact Personnel [Line Items]
Entity Address, Address Line One	289 Beach Road
Entity Address, Address Line Two	#03-01
Entity Address, City or Town	Singapore
Entity Address, Country	SG
Entity Address, Postal Zip Code	199552
Entity Phone Fax Numbers [Line Items]
City Area Code	(65)
Local Phone Number	6818 5796
Units, each consisting of one Class A ordinary share, with no par value, one-half of one redeemable warrant and one right to receive one-tenth of one Class A ordinary share
Entity Listings [Line Items]
Title of 12(b) Security	Units, each consisting of one Class A ordinary share, with no par value, one-half of one redeemable warrant and one right to receive one-tenth
Trading Symbol	ASCBU
Security Exchange Name	NASDAQ
Class A ordinary shares, no par value, included as part of the units
Entity Listings [Line Items]
Title of 12(b) Security	Class A ordinary shares, no par value, included as part of the units
Trading Symbol	ASCB
Security Exchange Name	NASDAQ
Redeemable warrants, each whole warrant exercisable for one Class A ordinary share, included as part of the units
Entity Listings [Line Items]
Title of 12(b) Security	Redeemable warrants, each whole warrant exercisable for one Class A ordinary share, included as part of the units
Trading Symbol	ASCBW
Security Exchange Name	NASDAQ
Rights, each Right to receive one-tenth (1/10) of one Class A ordinary share included as part of the units
Entity Listings [Line Items]
Title of 12(b) Security	Rights, each Right to receive one-tenth (1/10) of one Class A ordinary share included as part of the units
Trading Symbol	ASCBR
Security Exchange Name	NASDAQ
Class A Ordinary Shares
Entity Listings [Line Items]
Entity Common Stock, Shares Outstanding		7,196,395
Class B Ordinary Shares
Entity Listings [Line Items]
Entity Common Stock, Shares Outstanding		100,000

Condensed Balance Sheets - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash	$ 252,438	$ 442,147
Prepaid expenses	93,255	34,489
Total current assets	345,693	476,636
Investments held in Trust Account	22,181,297	21,895,685
Total Assets	22,526,990	22,372,321
Current liabilities:
Accounts payable and accrued expenses	169,678	157,354
Total current liabilities	169,678	157,354
Deferred underwriting fee payable	7,000,000	7,000,000
Total Liabilities	7,169,678	7,157,354
Commitments and Contingencies (Note 6)
Class A ordinary shares subject to possible redemption, no par value; 1,996,395 shares at redemption value of $11.111 and $10.968 per share as of March 31, 2024 and December 31, 2023, respectively	22,181,297	21,895,685
Shareholders’ Deficit
Preference shares, no par value; 1,000,000 shares authorized; none issued and outstanding
Additional paid-in capital
Accumulated deficit	(6,823,985)	(6,680,718)
Total Shareholders’ Deficit	(6,823,985)	(6,680,718)
Total Liabilities, Shares Subject to Redemption, and Shareholders’ Deficit	22,526,990	22,372,321
Class A Ordinary Shares
Shareholders’ Deficit
Common stock value
Class B Ordinary Shares
Shareholders’ Deficit
Common stock value

Condensed Balance Sheets (Parentheticals) - $ / shares	Mar. 31, 2024	Dec. 31, 2023
Ordinary shares subject to possible redemption, shares at redemption value	1,996,395	1,996,395
Ordinary shares subject to possible redemption, per share (in Dollars per share)	$ 11.111	$ 10.968
Ordinary shares subject to possible redemption, par value (in Dollars per share)
Preference shares, par value (in Dollars per share)
Preference shares, shares authorized	1,000,000	1,000,000
Preference shares, issued
Preference shares, outstanding
Class A Ordinary Shares
Ordinary shares subject to possible redemption, shares at redemption value		1,996,395
Ordinary shares, par value (in Dollars per share)
Ordinary shares, shares authorized	500,000,000	500,000,000
Ordinary shares, shares issued	5,200,000	5,200,000
Ordinary shares, shares outstanding	5,200,000	5,200,000
Class B Ordinary Shares
Ordinary shares, par value (in Dollars per share)
Ordinary shares, shares authorized	50,000,000	50,000,000
Ordinary shares, shares issued	100,000	100,000
Ordinary shares, shares outstanding	100,000	100,000

Unaudited Condensed Statements of Income - USD ($)	3 Months Ended
Unaudited Condensed Statements of Income - USD ($)	Mar. 31, 2024	Mar. 31, 2023
General and administrative expenses	$ 148,651	$ 197,239
Loss from operations	(148,651)	(197,239)
Other income:
Interest income	290,996	2,199,283
Income before income taxes	142,345	2,002,044
Income taxes provision
Net income	$ 142,345	$ 2,002,044
Class A Ordinary Shares Subject to Possible Redemption
Other income:
Basic weighted average shares outstanding (in Shares)	1,996,395	20,300,000
Basic net income (loss) per share (in Dollars per share)	$ 0.12	$ 0.1
Class A and Class B Ordinary Shares not Subject to Redemption
Other income:
Basic weighted average shares outstanding (in Shares)	5,300,000	5,000,000
Basic net income (loss) per share (in Dollars per share)	$ (0.02)	$ (0.01)

Unaudited Condensed Statements of Income (Parentheticals) - $ / shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Class A Ordinary Shares Subject to Possible Redemption
Diluted weighted average shares outstanding	1,996,395	20,300,000
Diluted net income (loss) per share	$ 0.12	$ 0.10
Class A and Class B Ordinary Shares not Subject to Redemption
Diluted weighted average shares outstanding	5,300,000	5,000,000
Diluted net income (loss) per share	$ (0.02)	$ (0.01)

Unaudited Condensed Statement of Changes in Shareholders’ Deficit - USD ($)	Ordinary Shares Class A	Ordinary Shares Class B	Accumulated Deficit	Total
Balance at Dec. 31, 2022			$ (5,873,067)	$ (5,873,067)
Balance (in Shares) at Dec. 31, 2022	300,000	5,000,000
Accretion of Class A ordinary shares to redemption value			(2,189,543)	(2,189,543)
Net Income			2,002,044	2,002,044
Balance at Mar. 31, 2023			(6,060,566)	(6,060,566)
Balance (in Shares) at Mar. 31, 2023	300,000	5,000,000
Balance at Dec. 31, 2023			(6,680,718)	(6,680,718)
Balance (in Shares) at Dec. 31, 2023	5,200,000	100,000
Accretion of Class A ordinary shares to redemption value			(285,612)	(285,612)
Net Income			142,345	142,345
Balance at Mar. 31, 2024			$ (6,823,985)	$ (6,823,985)
Balance (in Shares) at Mar. 31, 2024	5,200,000	100,000

Unaudited Condensed Statements of Cash Flows - USD ($)	3 Months Ended
Unaudited Condensed Statements of Cash Flows - USD ($)	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net income	$ 142,345	$ 2,002,044
Adjustments to reconcile net income to net cash used in operating activities:
Interest earned in trust account	(285,612)	(2,189,543)
Change in operating assets and liabilities:
Prepaid expenses and other assets	(58,766)	11,333
Accounts payable and accrued expenses	12,324	35,994
Net cash used in operating activities	(189,709)	(140,172)
Net change in cash	(189,709)	(140,172)
Cash, beginning of the period	442,147	1,063,837
Cash, end of the period	252,438	923,665
Supplemental Disclosure of Cash Flow Information:
Accretion of carrying value to redemption value	$ 285,612	$ 2,189,543

Description of Organization and Business Operation

3 Months Ended

Mar. 31, 2024

Description of Organization and Business Operation [Abstract]

Description of Organization and Business Operation

Note 1 – Description of Organization and Business Operation

Going Concern Consideration

As of March 31, 2024, the Company had cash of $252,438 and a working capital of $176,015.

Risks and Uncertainties

Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2024

Summary of Significant Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note 2 – Summary of Significant Accounting Policies

Basis of Presentation

Emerging Growth Company

Use of Estimates

Investment Held in Trust Account

Cash and Cash Equivalents

Concentration of Credit Risk

Class A Ordinary Shares Subject to Possible Redemption

Fair Value of Financial Instruments

Warrant Instruments

Net Income (Loss) Per Share

The net income (loss) per share presented in the statement of operations is based on the following:

	For the Three Months Ended March 31,
	2024			2023
Net income	$	142,345		$	2,002,044
Accretion of ordinary shares to redemption value		(285,612	)		(2,189,543	)
Net loss including accretion of ordinary shares to redemption value	$	(143,267	)	$	(187,499	)

	For the Three Months Ended March 31,
	2024						2023
	Redeemable Class A Ordinary Shares			Non-redeemable Class A and Class B Ordinary Shares			Redeemable Class A Ordinary Shares			Non-redeemable Class A and Class B Ordinary Shares
Basic and diluted net income (loss) per ordinary share
Numerator:
Allocation of net loss	$	(39,200	)	$	(104,067	)	$	(150,444	)	$	(37,055	)
Accretion of ordinary shares subject to possible redemption to redemption value		285,612			—			2,189,543			—
Allocation of net income (loss)		246,412			(104,067	)		2,039,099			(37,055	)

Denominator:
Basic and diluted weighted average shares outstanding		1,996,395			5,300,000			20,300,000			5,000,000
Basic and diluted net income (loss) per ordinary share	$	0.12		$	(0.02	)	$	0.10		$	(0.01	)

Income Taxes

Recent Accounting Pronouncements

Initial Public Offering

3 Months Ended

Mar. 31, 2024

Initial Public Offering [Abstract]

Initial Public Offering

Note 3 – Initial Public Offering

As of March 31, 2024 and December 31, 2023, the Class A Ordinary share reflected on the balance sheet are reconciled in the following table.

Gross proceeds from IPO	$	200,000,000
Less:
Proceeds allocated to Public Warrants and Public Rights		(15,500,000	)
Proceeds allocate to over-allotment liability		(67,450	)
Class A ordinary shares issuance cost		(12,109,127	)
Plus:
Remeasurement of carrying value to redemption value		34,032,804
Class A Ordinary shares subject to possible redemption - December 31, 2022		206,356,227
Plus:
Remeasurement of carrying value to redemption value		6,243,425
Less:
Payment to redeemed shareholders		(190,703,967	)
Class A Ordinary shares subject to possible redemption- December 31, 2023		21,895,685
Plus:
Remeasurement of carrying value to redemption value		285,612
Class A Ordinary shares subject to possible redemption- March 31, 2024	$	22,181,297

Private Placement Warrants

3 Months Ended

Mar. 31, 2024

Private Placement Warrants [Abstract]

Private Placement Warrants

Note 4 – Private Placement Warrants

Related Party Transactions

3 Months Ended

Mar. 31, 2024

Related Party Transactions

Note 5 – Related Party Transactions

Founder Shares

Promissory Note - Related Party

Working Capital Loans

Commitments & Contingencies

3 Months Ended

Mar. 31, 2024

Commitments & Contingencies [Abstract]

Commitments & Contingencies

Note 6 – Commitments & Contingencies

Registration & Shareholder Rights

Underwriting Agreement

Representative’s Class A Ordinary Shares

Shareholders’ Deficit

3 Months Ended

Mar. 31, 2024

Shareholders’ Deficit [Abstract]

Shareholders’ Deficit

Note 7—Shareholders’ Deficit

Ordinary shares

As of March 31, 2024 and December 31, 2023, there were 7,196,395 Class A Ordinary shares and 100,000 Class B Ordinary shares issued and outstanding.

Holders of Class A Ordinary shares and Class B Ordinary shares will vote together as a single class on all other matters submitted to a vote of stockholders except as required by law.

Redemption of warrants when the price per ordinary shares equals or exceeds $16.50.

Once the Warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):

in whole and not in part;

●

at a price of $0.01 per Warrant;

●

upon a minimum of 30 days’ prior written notice of redemption, which the Company refers to as the “30-day redemption period”; and

●

Fair Value Measurements

3 Months Ended

Mar. 31, 2024

Fair Value Measurements [Abstract]

Fair Value Measurements

Note 8—Fair Value Measurements

Level 1:

Level 2:

Level 3:

Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

	March 31,		Quoted Prices in Active Markets		Significant Other Observable Inputs		Significant Other Unobservable Inputs
	2024		(Level 1)		(Level 2)		(Level 3)
Assets
Marketable securities held in Trust Account	$	22,181,297	$	22,181,297		—		—

	December 31,		Quoted Prices in Active Markets		Significant Other Observable Inputs		Significant Other Unobservable Inputs
	2023		(Level 1)		(Level 2)		(Level 3)
Assets
Marketable securities held in Trust account	$	21,895,685	$	21,895,685		—		—

	May 5,
	2022		Level
Equity instrument:
Representative shares	$	2,202,589		3

Subsequent Events

3 Months Ended

Mar. 31, 2024

Subsequent Events [Abstract]

Subsequent Events

Note 9 – Subsequent Events

Pay vs Performance Disclosure - USD ($)	3 Months Ended
Pay vs Performance Disclosure - USD ($)	Mar. 31, 2024	Mar. 31, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ 142,345	$ 2,002,044

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Mar. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Accounting Policies, by Policy (Policies)

3 Months Ended

Mar. 31, 2024

Summary of Significant Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

Emerging Growth Company

Emerging Growth Company

Use of Estimates

Use of Estimates

Investment Held in Trust Account

Investment Held in Trust Account

Cash and cash equivalents

Cash and Cash Equivalents

Concentration of Credit Risk

Concentration of Credit Risk

Class A Ordinary Shares Subject to Possible Redemption

Class A Ordinary Shares Subject to Possible Redemption

Fair Value of Financial Instruments

Fair Value of Financial Instruments

Warrant Instruments

Warrant Instruments

Net Income (Loss) Per Share

Net Income (Loss) Per Share

The net income (loss) per share presented in the statement of operations is based on the following:

	For the Three Months Ended March 31,
	2024			2023
Net income	$	142,345		$	2,002,044
Accretion of ordinary shares to redemption value		(285,612	)		(2,189,543	)
Net loss including accretion of ordinary shares to redemption value	$	(143,267	)	$	(187,499	)

	For the Three Months Ended March 31,
	2024						2023
	Redeemable Class A Ordinary Shares			Non-redeemable Class A and Class B Ordinary Shares			Redeemable Class A Ordinary Shares			Non-redeemable Class A and Class B Ordinary Shares
Basic and diluted net income (loss) per ordinary share
Numerator:
Allocation of net loss	$	(39,200	)	$	(104,067	)	$	(150,444	)	$	(37,055	)
Accretion of ordinary shares subject to possible redemption to redemption value		285,612			—			2,189,543			—
Allocation of net income (loss)		246,412			(104,067	)		2,039,099			(37,055	)

Denominator:
Basic and diluted weighted average shares outstanding		1,996,395			5,300,000			20,300,000			5,000,000
Basic and diluted net income (loss) per ordinary share	$	0.12		$	(0.02	)	$	0.10		$	(0.01	)

Income Taxes

Income Taxes

Recent Accounting Pronouncements

Recent Accounting Pronouncements

Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2024

Summary of Significant Accounting Policies [Abstract]

Schedule of Net Income (Loss) Per Share

The net income (loss) per share presented in the statement of operations is based on the following:

	For the Three Months Ended March 31,
	2024			2023
Net income	$	142,345		$	2,002,044
Accretion of ordinary shares to redemption value		(285,612	)		(2,189,543	)
Net loss including accretion of ordinary shares to redemption value	$	(143,267	)	$	(187,499	)

	For the Three Months Ended March 31,
	2024						2023
	Redeemable Class A Ordinary Shares			Non-redeemable Class A and Class B Ordinary Shares			Redeemable Class A Ordinary Shares			Non-redeemable Class A and Class B Ordinary Shares
Basic and diluted net income (loss) per ordinary share
Numerator:
Allocation of net loss	$	(39,200	)	$	(104,067	)	$	(150,444	)	$	(37,055	)
Accretion of ordinary shares subject to possible redemption to redemption value		285,612			—			2,189,543			—
Allocation of net income (loss)		246,412			(104,067	)		2,039,099			(37,055	)

Denominator:
Basic and diluted weighted average shares outstanding		1,996,395			5,300,000			20,300,000			5,000,000
Basic and diluted net income (loss) per ordinary share	$	0.12		$	(0.02	)	$	0.10		$	(0.01	)

Initial Public Offering (Tables)

3 Months Ended

Mar. 31, 2024

Initial Public Offering [Abstract]

Schedule of Class A Ordinary Share

As of March 31, 2024 and December 31, 2023, the Class A Ordinary share reflected on the balance sheet are reconciled in the following table.

Gross proceeds from IPO	$	200,000,000
Less:
Proceeds allocated to Public Warrants and Public Rights		(15,500,000	)
Proceeds allocate to over-allotment liability		(67,450	)
Class A ordinary shares issuance cost		(12,109,127	)
Plus:
Remeasurement of carrying value to redemption value		34,032,804
Class A Ordinary shares subject to possible redemption - December 31, 2022		206,356,227
Plus:
Remeasurement of carrying value to redemption value		6,243,425
Less:
Payment to redeemed shareholders		(190,703,967	)
Class A Ordinary shares subject to possible redemption- December 31, 2023		21,895,685
Plus:
Remeasurement of carrying value to redemption value		285,612
Class A Ordinary shares subject to possible redemption- March 31, 2024	$	22,181,297

Fair Value Measurements (Tables)

3 Months Ended

Mar. 31, 2024

Fair Value Measurements [Abstract]

Schedule of Fair Value Hierarchy of the Valuation Inputs

	March 31,		Quoted Prices in Active Markets		Significant Other Observable Inputs		Significant Other Unobservable Inputs
	2024		(Level 1)		(Level 2)		(Level 3)
Assets
Marketable securities held in Trust Account	$	22,181,297	$	22,181,297		—		—

	December 31,		Quoted Prices in Active Markets		Significant Other Observable Inputs		Significant Other Unobservable Inputs
	2023		(Level 1)		(Level 2)		(Level 3)
Assets
Marketable securities held in Trust account	$	21,895,685	$	21,895,685		—		—

Schedule of Fair Value on a Non-Recurring Basis and Indicates the Fair Value Hierarchy of the Valuation Inputs

	May 5,
	2022		Level
Equity instrument:
Representative shares	$	2,202,589		3

Description of Organization and Business Operation (Details)				3 Months Ended
	Dec. 11, 2023 USD ($)	Dec. 07, 2023 shares	May 05, 2022 USD ($) $ / shares shares	Mar. 31, 2024 USD ($) $ / shares shares	Aug. 01, 2023 shares
Description of Organization and Business Operation [Line Items]
Number of business combination				1
Share price, per share (in Dollars per share) \| $ / shares				$ 9.2
Warrants price per share (in Dollars per share) \| $ / shares				$ 1
Transaction costs (in Dollars) \| $				$ 13,150,218
Underwriting fees (in Dollars) \| $				3,380,000
Deferred underwriting fees (in Dollars) \| $				7,000,000
Other offering costs (in Dollars) \| $				567,629
Fair value (in Dollars) \| $				$ 2,202,589
Representative shares				300,000
Trust account per public share (in Dollars per share) \| $ / shares				$ 10.175
Net tangible assets least (in Dollars) \| $				$ 5,000,001
Percentage of redeem public shares				100.00%
Interest dissolution expenses (in Dollars) \| $				$ 50,000
Initially held in trust account, per share (in Dollars per share) \| $ / shares				$ 10
Redemption shares				4,900,000	18,003,605
Securities requirement (in Dollars) \| $	$ 50,000,000
Cash (in Dollars) \| $				$ 252,438
working capital (in Dollars) \| $				176,015
Maxim Group LLC [Member]
Description of Organization and Business Operation [Line Items]
Fair value (in Dollars) \| $				$ 2,202,589
Class A Ordinary Shares [Member]
Description of Organization and Business Operation [Line Items]
Share price, per share (in Dollars per share) \| $ / shares				$ 11.5
Representative shares				300,000
Redemption shares					190,703,967
Transferred shares				4,900,000
Number of shares issued				7,196,395
Number of shares outstanding				7,196,395
Class A Ordinary Shares [Member] \| Sponsor [Member]
Description of Organization and Business Operation [Line Items]
Percentage of outstanding share		68.10%		68.10%
Share exchanged		4,900,000		4,900,000
Class B Ordinary Shares [Member]
Description of Organization and Business Operation [Line Items]
Transferred shares				4,900,000
Number of shares issued				100,000
Number of shares outstanding				100,000
Class B Ordinary Shares [Member] \| Sponsor [Member]
Description of Organization and Business Operation [Line Items]
Share exchanged		4,900,000
Initial Public Offering [Member]
Description of Organization and Business Operation [Line Items]
Initial public offering			20,000,000
Share price, per share (in Dollars per share) \| $ / shares			$ 10
Gross proceeds (in Dollars) \| $			$ 200,000,000
Amount of net proceeds from sale of units (in Dollars) \| $			$ 203,500,000
Net proceeds per share (in Dollars per share) \| $ / shares			$ 10.175
Redemption shares				20,000,000
Over-Allotment Option [Member]
Description of Organization and Business Operation [Line Items]
Initial public offering			1,500,000
Over-Allotment Option [Member] \| Class A Ordinary Shares [Member]
Description of Organization and Business Operation [Line Items]
Number of shares issued				300,000
Private Placement [Member]
Description of Organization and Business Operation [Line Items]
Warrants share			8,966,000
Warrants price per share (in Dollars per share) \| $ / shares			$ 1
Proceeds (in Dollars) \| $			$ 8,966,000

Summary of Significant Accounting Policies (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Summary of Significant Accounting Policies [Abstract]
Cash	$ 252,438	$ 442,147
Federal depository	$ 250,000
Redemption value (in Dollars per share)	$ 11.111	$ 10.968

Summary of Significant Accounting Policies (Details) - Schedule of Net Income (Loss) Per Share - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Schedule of Net Income (Loss) Per Share [Line Items]
Net income	$ 142,345	$ 2,002,044
Accretion of ordinary shares to redemption value	(285,612)	(2,189,543)
Net loss including accretion of ordinary shares to redemption value	(143,267)	(187,499)
Redeemable Class A Ordinary Shares [Member]
Schedule of Net Income (Loss) Per Share [Line Items]
Net income	246,412	2,039,099
Accretion of ordinary shares to redemption value	285,612	2,189,543
Numerator:
Allocation of net loss	$ (39,200)	$ (150,444)
Denominator:
Basic and diluted weighted average shares outstanding (in Shares)	1,996,395	20,300,000
Basic and diluted net income (loss) per ordinary share (in Dollars per share)	$ 0.12	$ 0.1
Non-redeemable Class A and Class B Ordinary Shares [Member]
Schedule of Net Income (Loss) Per Share [Line Items]
Net income	$ (104,067)	$ (37,055)
Accretion of ordinary shares to redemption value
Numerator:
Allocation of net loss	$ (104,067)	$ (37,055)
Denominator:
Basic and diluted weighted average shares outstanding (in Shares)	5,300,000	5,000,000
Basic and diluted net income (loss) per ordinary share (in Dollars per share)	$ (0.02)	$ (0.01)

Summary of Significant Accounting Policies (Details) - Schedule of Net Income (Loss) Per Share (Parentheticals) - $ / shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Redeemable Class A Ordinary Shares [Member]
Schedule of Net Income (Loss) Per Share [Line Items]
Diluted weighted average shares outstanding	1,996,395	20,300,000
Diluted net income (loss) per ordinary share	$ 0.12	$ 0.10
Non-redeemable Class A and Class B Ordinary Shares [Member]
Schedule of Net Income (Loss) Per Share [Line Items]
Diluted weighted average shares outstanding	5,300,000	5,000,000
Diluted net income (loss) per ordinary share	$ (0.02)	$ (0.01)

Initial Public Offering (Details) - IPO [Member] - $ / shares		3 Months Ended
	May 05, 2022	Mar. 31, 2024
Initial Public Offering [Line Items]
Company sold units	20,000,000
Shares issued price per share (in Dollars per share)	$ 10
Sale of stock, description		Each Unit consists of one Class A Ordinary Share, one-half of one redeemable warrant (“Public Warrant”), and one right to receive one-tenth (1/10) of one Class A ordinary share at the closing of the Company’s Business Combination (“Public Right”).
Public shares		20,000,000

Initial Public Offering (Details) - Schedule of Class A Ordinary Share - Class A Ordinary Shares [Member] - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Temporary Equity [Line Items]
Gross proceeds from IPO			$ 200,000,000
Less:
Proceeds allocated to Public Warrants and Public Rights			(15,500,000)
Proceeds allocate to over-allotment liability			(67,450)
Class A ordinary shares issuance cost			(12,109,127)
Plus:
Remeasurement of carrying value to redemption value	$ 285,612	$ 6,243,425	34,032,804
Less:
Payment to redeemed shareholders		(190,703,967)
Class A Ordinary shares subject to possible redemption	22,181,297	$ 21,895,685
Class A Ordinary shares subject to possible redemption	$ 21,895,685		$ 206,356,227

Private Placement Warrants (Details) - Private Placement Warrants [Member]	3 Months Ended
	Mar. 31, 2024 USD ($) $ / shares shares
Private Placement Warrants [Line Items]
Sponsor purchased shares \| shares	8,966,000
Warrants at a price per share \| $ / shares	$ 1
Purchase price \| $	$ 8,966,000

Related Party Transactions (Details) - USD ($)					1 Months Ended	3 Months Ended
Related Party Transactions (Details) - USD ($)	Dec. 07, 2023	May 05, 2022	Jul. 08, 2021	Jun. 28, 2021	Mar. 24, 2022	Mar. 31, 2024
Related Party Transactions [Line Items]
Cancelled founder shares					431,250
Founder share outstanding					5,318,750
Shares subject to forfeiture					693,750
Founder shares						693,750
Issued and outstanding shares after the IPO percentage						20.00%
Over-allotment option		318,750
Class A ordinary shares equals or exceeds per share (in Dollars per share)						$ 12
Aggregate to cover expenses related to the IPO (in Dollars)			$ 400,000
Working capital loans (in Dollars)						$ 1,150,000
Price per warrant (in Dollars per share)						$ 1
Founder shares [Member] \| Sponsor [Member]
Related Party Transactions [Line Items]
Shares purchased				5,750,000
Class B Ordinary Shares [Member]
Related Party Transactions [Line Items]
Shares issued						100,000
Number of shares outstanding						100,000
Class B Ordinary Shares [Member] \| Sponsor [Member]
Related Party Transactions [Line Items]
Share exchanged	4,900,000
Class A Ordinary Shares [Member]
Related Party Transactions [Line Items]
Shares issued						7,196,395
Number of shares outstanding						7,196,395
Class A Ordinary Shares [Member] \| Sponsor [Member]
Related Party Transactions [Line Items]
Share exchanged	4,900,000					4,900,000
Percentage of outstanding share	68.10%					68.10%
Class A Ordinary Shares [Member] \| Founder shares [Member]
Related Party Transactions [Line Items]
Share exchanged	4,900,000					4,900,000
Founder shares [Member] \| Class B Ordinary Shares [Member]
Related Party Transactions [Line Items]
Aggregate price (in Dollars)				$ 25,000

Commitments & Contingencies (Details) - USD ($)		3 Months Ended
Commitments & Contingencies (Details) - USD ($)	May 05, 2022	Mar. 31, 2024	Dec. 31, 2023
Commitments & Contingencies [Line Items]
Underwriting discount, per share		$ 0.169
Cash underwriting discount		$ 3,380,000
Deferred underwriting commission, per unit		$ 0.35
Deferred commission		$ 7,000,000
Partial exercise shares		22,500
Risk-free rate		2.14%
Volatility rate		2.10%
Estimated term		1 year 1 month 6 days
Fair value of shares		300,000
Amount of representative share		$ 2,202,589
Fair value per share		$ 7.34
Class A Ordinary Shares [Member]
Commitments & Contingencies [Line Items]
Purchase of units		7,196,395	7,196,395
Issued shares		7,196,395
Fair value of shares		300,000
IPO [Member]
Commitments & Contingencies [Line Items]
Purchase of units		2,775,000
Over-Allotment Option [Member]
Commitments & Contingencies [Line Items]
Purchase of units	1,500,000
Generating gross proceeds	$ 15,000,000
Deferred commission		$ 1,500,000
Over-Allotment Option [Member] \| Class A Ordinary Shares [Member]
Commitments & Contingencies [Line Items]
Issued shares		300,000

Shareholders’ Deficit (Details) - $ / shares			1 Months Ended	3 Months Ended
Shareholders’ Deficit (Details) - $ / shares	Dec. 07, 2023	May 05, 2022	Mar. 24, 2022	Mar. 31, 2024	Dec. 31, 2023
Shareholders’ Equity [Line Items]
Preference shares authorized				1,000,000	1,000,000
Subject to possible redemption				1,996,395	1,996,395
Number of shares canceled			431,250
Outstanding founder shares			5,318,750
Subject to forfeiture			693,750
Over-allotment option		318,750
Issued and outstanding percentage				20.00%
Issued price, per share (in Dollars per share)				$ 9.2
Public warrants				5 years
Warrants outstanding				9,999,989	9,999,989
Ordinary price, per share (in Dollars per share)				$ 16.5
Price per share (in Dollars per share)				$ 1
Trading days				20 days
Number of trading day period				30 days
Aggregate gross proceeds, percentage				60.00%
Market price per share (in Dollars per share)				$ 9.2
Exercise price warrants, percentage				115.00%
Redemption trigger price, per share (in Dollars per share)				$ 16.5
Higher market value, percentage				165.00%
Public warrants outstanding				20,000,000
Warrant [Member]
Shareholders’ Equity [Line Items]
Price per share (in Dollars per share)				$ 0.01
Class A Ordinary Shares [Member]
Shareholders’ Equity [Line Items]
Common stock, shares authorized				500,000,000	500,000,000
Ordinary shares, shares outstanding				5,200,000	5,200,000
Subject to possible redemption					1,996,395
Ordinary shares, issued				7,196,395	7,196,395
Ordinary shares,Shares outstanding				7,196,395	7,196,395
Ordinary shares, shares issued				5,200,000	5,200,000
Issued price, per share (in Dollars per share)				$ 11.5
Class A Ordinary Shares [Member] \| Sponsor [Member]
Shareholders’ Equity [Line Items]
Share exchanged	4,900,000			4,900,000
Percentage of outstanding share	68.10%			68.10%
Class A Ordinary Shares [Member] \| Founder shares [Member]
Shareholders’ Equity [Line Items]
Share exchanged	4,900,000			4,900,000
Class B Ordinary Shares [Member]
Shareholders’ Equity [Line Items]
Common stock, shares authorized				50,000,000	50,000,000
Ordinary shares, shares outstanding				100,000	100,000
Ordinary shares, shares issued				100,000	100,000
Class B Ordinary Shares [Member] \| Sponsor [Member]
Shareholders’ Equity [Line Items]
Share exchanged	4,900,000
Ordinary Shares [Member]
Shareholders’ Equity [Line Items]
Issued price, per share (in Dollars per share)				$ 16.5

Fair Value Measurements (Details)	3 Months Ended
Fair Value Measurements (Details)	Mar. 31, 2024 USD ($) $ / shares shares
Fair Value Measurements [Abstract]
Risk free rate	2.14%
Volatility	2.10%
Estimated term	1 year 1 month 6 days
Fair value of shares (in Shares) \| shares	300,000
Fair value of representative shares (in Dollars) \| $	$ 2,202,589
Fair value per share (in Dollars per share) \| $ / shares	$ 7.34

Fair Value Measurements (Details) - Schedule of Fair Value Hierarchy of the Valuation Inputs - Fair Value, Recurring [Member] - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Assets
Marketable securities held in Trust Account	$ 22,181,297	$ 21,895,685
Quoted Prices in Active Markets (Level 1) [Member]
Assets
Marketable securities held in Trust Account	22,181,297	21,895,685
Significant Other Observable Inputs (Level 2) [Member]
Assets
Marketable securities held in Trust Account
Significant Other Unobservable Inputs (Level 3) [Member]
Assets
Marketable securities held in Trust Account

Fair Value Measurements (Details) - Schedule of Fair Value on a Non-Recurring Basis and Indicates the Fair Value Hierarchy of the Valuation Inputs	May 05, 2022 USD ($)
Level 3 [Member]
Equity instrument:
Representative shares	$ 2,202,589

A SPAC II Acquisition (NASDAQ:ASCBW)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024

Plus de graphiques de la Bourse A SPAC II Acquisition

A SPAC II Acquisition (NASDAQ:ASCBW)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024

	Prix en temps réel	Carnet d'ordres
BATS Europe
Chi-X Europe
Euronext

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

ASCBW A SPAC II Acquisition Corporation

Actualités A SPAC II Acquisition Corporation

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

ASCBW A SPAC II Acquisition Corporation

Actualités A SPAC II Acquisition Corporation

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

BLACK FRIDAY

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres